Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kamran M. Miah"'
Autor:
Yue Du, Shengnan Zhang, Zhaoyong Zhang, Kamran M. Miah, Peilan Wei, Lu Zhang, Yuhui Zhu, Zhengtu Li, Feng Ye, Deborah R. Gill, Stephen C. Hyde, Yanqun Wang, Jincun Zhao
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Vaccines for COVID-19 are now a crucial public health need, but the degree of protection provided by conventional vaccinations for individuals with compromised immune systems is unclear. The use of viral vectors to express neutralizing monoclonal ant
Externí odkaz:
https://doaj.org/article/882b0663b0c74c2d88e868f70d05fc7a
Autor:
Gerry McLachlan, Eric W.F.W. Alton, A. Christopher Boyd, Nora K. Clarke, Jane C. Davies, Deborah R. Gill, Uta Griesenbach, Jack W. Hickmott, Stephen C. Hyde, Kamran M. Miah, Claudia Juarez Molina
Publikováno v:
McLachlan, G, Alton, E W, Boyd, A C, Clark, N, Davies, J C, Gill, D R, Griesenbach, U, Hickmott, J, Hyde, S C, Miah, K & Juarez Molina, C 2022, ' Progress in Respiratory Gene Therapy ', Human Gene Therapy, vol. 33, no. 17-18, pp. 893-912 . https://doi.org/10.1089/hum.2022.172
The prospect of gene therapy for inherited and acquired respiratory disease has energized the research community since the 1980s, with cystic fibrosis, as a monogenic disorder, driving early efforts to develop effective strategies. The fact that ther
Autor:
Yue Du, Kamran M Miah, Omar Habib, Helena Meyer-Berg, Catriona C Conway, Mariana A Viegas, Rebecca Dean, Dwiantari Satyapertiwi, Jincun Zhao, Yanqun Wang, Nigel J Temperton, Toby P E Gamlen, Deborah R Gill, Stephen C Hyde
Publikováno v:
Thorax. 77:1229-1236
BackgroundThe COVID-19 pandemic continues to be a worldwide threat and effective antiviral drugs and vaccines are being developed in a joint global effort. However, some elderly and immune-compromised populations are unable to raise an effective immu
Autor:
null Patricia P. Ogger, null Minerva Garcia Martín, null Christina Michalaki, null Jie Zhou, null Jonathan C. Brown, null Yue Du, null Kamran M. Miah, null Omar Habib, null Stephen C. Hyde, null Deborah R. Gill, null Wendy S. Barclay, null Cecilia Johansson
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab2b52f860cd194835530db57e0768f4
https://doi.org/10.1002/eji.202249913/v3/response1
https://doi.org/10.1002/eji.202249913/v3/response1
Autor:
Yue, Du, Shengnan, Zhang, Zhaoyong, Zhang, Kamran M, Miah, Peilan, Wei, Lu, Zhang, Yuhui, Zhu, Zhengtu, Li, Feng, Ye, Deborah R, Gill, Stephen C, Hyde, Yanqun, Wang, Jincun, Zhao
Vaccines for COVID-19 are now a crucial public health need, but the degree of protection provided by conventional vaccinations for individuals with compromised immune systems is unclear. The use of viral vectors to express neutralizing monoclonal ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0553130f4b4b1e6e53b9ebd0a7d546d
https://ora.ox.ac.uk/objects/uuid:0a008c18-cfd7-4f5d-8819-5251817e3c88
https://ora.ox.ac.uk/objects/uuid:0a008c18-cfd7-4f5d-8819-5251817e3c88
Publikováno v:
Expert Review of Respiratory Medicine. 13:709-725
Introduction: Cystic fibrosis (CF) remains a life-threatening genetic disease, with few clinically effective treatment options. Gene therapy and gene editing strategies offer the potential for a one-time CF cure, irrespective of theCFTRmutation class